The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology

Patricio S Espinosa

Open source

DOI
10.7759/cureus.111414
Published
2026-06-24
Container
Cureus
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.111414,
  title = {The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology},
  author = {Patricio S Espinosa},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.111414},
  url = {https://doi.org/10.7759/cureus.111414}
}

RIS

TY  - JOUR
TI  - The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology
AU  - Patricio S Espinosa
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.111414
UR  - https://doi.org/10.7759/cureus.111414
ER  - 

APA

Espinosa, P. S. (2026). The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology. Cureus. https://doi.org/10.7759/cureus.111414

Source records